Ligand Pharma (LGND) PT Raised to $255 at Stifel

April 27, 2026 1:56 PM

Stifel analyst Annabel Samimy raised the price target on Ligand Pharma (NASDAQ: LGND) to $255.00 (from $230.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found